Treatment of Cushing's disease in juveniles with interstitial pituitary irradiation.
Nine juvenile patients (five boys and four girls aged 10--18 with Cushing's disease were treated with pituitary implantation of 198Au and/or 90Y. No patient had any surgical complication from the procedure. At the latest assessment, 3 months to 17 years after operation, Cushing's disease was in remission in all the patients; the response time following operation was a few days to 3 months. Radiology of the pituitary fossa at time of pituitary implantation was normal in all patients and remains so. The final height in six patients is 149--172 cm (59--67.5 inches) and three patients who continue to grow have increased by 13, 6 and 3 cm since implantation. Only one patient required full pituitary hormone replacement therapy, and he had been previously treated by external irradiation, and one other patient failed to complete puberty. In all the other seven sexual maturation is normal and one has fathered two children. We conclude that pituitary implantation with interstitial irradiation is a satisfactory form of treatment for Cushing's disease in juveniles.
D000293:Adolescent; D001918:Brachytherapy; D002648:Child; D003480:Cushing Syndrome / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000532:radiotherapy*; D005260:Female; D006050:Gold Radioisotopes; D006801:Humans; D008297:Male; D010901:Pituitary Function Tests; D010903:Pituitary Gland, Anterior / Q000503:physiopathology; D010910:Pituitary Irradiation; D010912:Pituitary-Adrenal Function Tests; D011859:Radiography; D015021:Yttrium Radioisotopes
D006050:Gold Radioisotopes; D015021:Yttrium Radioisotopes